Your browser doesn't support javascript.
loading
Anti-inflammatory and atheroprotective properties of glucagon.
Osaka, Naoya; Kushima, Hideki; Mori, Yusaku; Saito, Tomomi; Hiromura, Munenori; Terasaki, Michishige; Yashima, Hironori; Ohara, Makoto; Fukui, Tomoyasu; Matsui, Takanori; Hirano, Tsutomu; Yamagishi, Sho-Ichi.
Afiliação
  • Osaka N; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan.
  • Kushima H; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan.
  • Mori Y; Anti-glycation Research Section, Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan.
  • Saito T; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan.
  • Hiromura M; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan.
  • Terasaki M; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan.
  • Yashima H; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan.
  • Ohara M; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan.
  • Fukui T; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan.
  • Matsui T; Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
  • Hirano T; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan.
  • Yamagishi SI; Diabetes Center, Ebina General Hospital, Ebina, Kanagawa, Japan.
Diab Vasc Dis Res ; 17(5): 1479164120965183, 2020.
Article em En | MEDLINE | ID: mdl-33076703
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aorta / Doenças da Aorta / Glucagon / Receptores de Glucagon / Aterosclerose / Anti-Inflamatórios Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Diab Vasc Dis Res Assunto da revista: ANGIOLOGIA / ENDOCRINOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aorta / Doenças da Aorta / Glucagon / Receptores de Glucagon / Aterosclerose / Anti-Inflamatórios Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Diab Vasc Dis Res Assunto da revista: ANGIOLOGIA / ENDOCRINOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão